Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 638,496 | 385,693 | 270,600 | 50,037 | 0 |
| Cost of Goods | 47,478 | 33,303 | 26,065 | 5,198 | N/A |
| Gross Profit | 591,018 | 352,390 | 244,535 | 44,839 | N/A |
| Operating Expenses | 758,258 | 633,255 | 476,425 | 224,836 | 124,707 |
| Operating Income | -166,762 | -280,562 | -231,825 | -179,799 | -124,707 |
| Interest Expense | 6,557 | 6,569 | 6,453 | 7,335 | 5,696 |
| Other Income | -10,385 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -183,704 | -287,131 | -238,278 | -187,134 | -130,403 |
| Income Tax | -530 | 85 | 960 | N/A | N/A |
| Net Income Continuous | -183,174 | -287,216 | -239,238 | -187,134 | -130,403 |
| Net Income | $-183,174 | $-287,216 | $-239,238 | $-187,134 | $-130,403 |
| EPS Basic Total Ops | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 |
| EPS Basic Continuous Ops | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 |
| EPS Diluted Total Ops | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 |
| EPS Diluted Continuous Ops | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 |
| EPS Diluted Before Non-Recurring Items | -3.39 | -3.93 | -2.67 | -4.42 | -3.47 |
| EBITDA(a) | $-156,395 | $-269,964 | $-222,417 | $-173,914 | $-123,554 |